Mohammad E. Naffaa

537 total citations
21 papers, 94 citations indexed

About

Mohammad E. Naffaa is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Dermatology. According to data from OpenAlex, Mohammad E. Naffaa has authored 21 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Dermatology. Recurrent topics in Mohammad E. Naffaa's work include Vasculitis and related conditions (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Mohammad E. Naffaa is often cited by papers focused on Vasculitis and related conditions (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Mohammad E. Naffaa collaborates with scholars based in Israel and United States. Mohammad E. Naffaa's co-authors include Zaher S. Azzam, Eyal Braun, Tanya Mashiach, Marielle Kaplan, Walid Saliba, Badira F. Makhoul, Doron Aronson, Ziv Paz, Eyal Klang and Chaim Putterman and has published in prestigious journals such as Lara D. Veeken, Scandinavian Journal of Gastroenterology and BMC Infectious Diseases.

In The Last Decade

Mohammad E. Naffaa

16 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad E. Naffaa Israel 6 26 24 23 17 15 21 94
Kelly Budge United States 6 49 1.9× 23 1.0× 7 0.3× 6 0.4× 19 1.3× 9 147
Zelal Ekinci Türkiye 8 54 2.1× 34 1.4× 50 2.2× 11 0.6× 15 1.0× 14 155
Hani Susianti Indonesia 6 47 1.8× 63 2.6× 11 0.5× 10 0.6× 13 0.9× 45 155
Tuncer Temel Türkiye 6 19 0.7× 13 0.5× 46 2.0× 6 0.4× 4 0.3× 22 113
Julien Dang France 6 16 0.6× 10 0.4× 15 0.7× 4 0.2× 5 0.3× 15 91
Elżbieta Kuźma-Mroczkowska Poland 6 8 0.3× 26 1.1× 8 0.3× 4 0.2× 10 0.7× 11 77
Matthias Cassia Italy 5 33 1.3× 39 1.6× 9 0.4× 4 0.2× 8 0.5× 12 94
Ayşegül Oruç Türkiye 8 34 1.3× 11 0.5× 13 0.6× 5 0.3× 6 0.4× 40 151
Edgardo Járes Argentina 8 29 1.1× 55 2.3× 9 0.4× 3 0.2× 23 1.5× 23 280
Yuta Yamamura Japan 9 23 0.9× 15 0.6× 18 0.8× 3 0.2× 10 0.7× 25 153

Countries citing papers authored by Mohammad E. Naffaa

Since Specialization
Citations

This map shows the geographic impact of Mohammad E. Naffaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad E. Naffaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad E. Naffaa more than expected).

Fields of papers citing papers by Mohammad E. Naffaa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad E. Naffaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad E. Naffaa. The network helps show where Mohammad E. Naffaa may publish in the future.

Co-authorship network of co-authors of Mohammad E. Naffaa

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad E. Naffaa. A scholar is included among the top collaborators of Mohammad E. Naffaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad E. Naffaa. Mohammad E. Naffaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naffaa, Mohammad E., et al.. (2025). The Role of Neutrophil to Lymphocytes Ratio (NLR) as a Predictor of Disease Activity in Behcet’s Syndrome—A Comprehensive Review. Journal of Clinical Medicine. 14(16). 5847–5847.
2.
Naffaa, Mohammad E., et al.. (2025). Long-term use of colchicine is associated with incident cirrhosis: a real-world cohort study. Scandinavian Journal of Gastroenterology. 60(4). 361–367. 2 indexed citations
3.
4.
Carmiel-Haggai, Michal, et al.. (2025). The association between familial Mediterranean fever and incident cirrhosis: A population-based matched cohort study. Joint Bone Spine. 92(6). 105917–105917.
5.
Omar, Mahmud, Mohammad E. Naffaa, ‬‬‬‬Abdulla Watad, et al.. (2025). Applications of Artificial Intelligence in Vasculitides: A Systematic Review. ACR Open Rheumatology. 7(3). e70016–e70016. 1 indexed citations
6.
Omar, Mahmud, et al.. (2024). Advancing rheumatology with natural language processing: insights and prospects from a systematic review. Rheumatology Advances in Practice. 8(4). rkae120–rkae120. 8 indexed citations
7.
8.
Omar, Mahmud, et al.. (2024). Large Language Models in Rheumatologic Diagnosis: A Multimodal Performance Analysis. The Journal of Rheumatology. 52(2). jrheum.2024–975. 1 indexed citations
9.
Naffaa, Mohammad E., et al.. (2024). Rheumatic manifestations and sequela of acute parvovirus B19 infection in hospitalized adult population. International Journal of Rheumatic Diseases. 27(11). e15409–e15409. 2 indexed citations
10.
Golan‐Cohen, Avivit, et al.. (2023). Biologic therapy is associated with malignancies among Israeli patients with rheumatoid arthritis: A population‐based study. International Journal of Rheumatic Diseases. 26(7). 1330–1336. 4 indexed citations
11.
Basheer, Maamoun, et al.. (2023). Neurosarcoidosis: The Presentation, Diagnosis and Treatment Review of Two Cases. Life. 14(1). 69–69. 2 indexed citations
12.
Naffaa, Mohammad E., et al.. (2023). Challenges in the Timely Diagnosis of Behcet’s Disease. Life. 13(5). 1157–1157. 3 indexed citations
13.
Naffaa, Mohammad E., et al.. (2023). A very rare cause of blue finger: A case-based review. Journal of Scleroderma and Related Disorders. 8(3). NP1–NP5. 1 indexed citations
14.
Henig, Israel, Tsila Zuckerman, Lisa Kaly, et al.. (2023). Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy. Lara D. Veeken. 63(6). 1534–1538. 12 indexed citations
15.
Naffaa, Mohammad E., et al.. (2022). Normotensive scleroderma renal crisis as the presenting symptom of systemic sclerosis sine scleroderma: A case report. Journal of Scleroderma and Related Disorders. 8(1). NP1–NP5.
16.
Naffaa, Mohammad E., et al.. (2022). Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers. Brain Sciences. 12(2). 222–222. 6 indexed citations
17.
Naffaa, Mohammad E., et al.. (2021). Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study. Rheumatology International. 41(11). 1905–1913. 5 indexed citations
18.
Nissim, Lior, et al.. (2020). The impact of gender on the clinical presentation, management, and surgical outcomes of patients with native‐joint septic arthritis. Journal of Evaluation in Clinical Practice. 27(2). 371–376. 4 indexed citations
19.
Naffaa, Mohammad E., et al.. (2018). The association between serum magnesium levels and community-acquired pneumonia 30-day mortality. BMC Infectious Diseases. 18(1). 698–698. 21 indexed citations
20.
Naffaa, Mohammad E., Badira F. Makhoul, Marielle Kaplan, et al.. (2013). Interleukin-6 at discharge predicts all-cause mortality in patients with sepsis. The American Journal of Emergency Medicine. 31(9). 1361–1364. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly Budge Breakdown of academic impact, for papers by Zelal Ekinci Breakdown of academic impact, for papers by Hani Susianti Breakdown of academic impact, for papers by Tuncer Temel Breakdown of academic impact, for papers by Julien Dang Breakdown of academic impact, for papers by Elżbieta Kuźma-Mroczkowska Breakdown of academic impact, for papers by Matthias Cassia Breakdown of academic impact, for papers by Ayşegül Oruç Breakdown of academic impact, for papers by Edgardo Járes Breakdown of academic impact, for papers by Yuta Yamamura
Rankless by CCL
2026